Contralateral delayed hematoma secondary to anticoagulant treatment-related intracerebral hemorrhage.
: The incidence of anticoagulant treatment (AT)-related intracerebral hemorrhage (AT-ICH) is increasing in consequence of the increased incidence of ischemic stroke due to an aging population. AT-ICH is associated with a risk of ongoing bleeding, death, or disability. Cerebral amyloid angiopathy (CAA), a common pathological finding among the elderly that is associated with macro- and microscopic hematoma development, might increase the risk of ICH. We report a rare case of contralateral delayed hematoma in the context of CAA secondary to acute ICH after AT for intracerebral ischemic stroke....
Citation
Sun L, Gao Y, Fu C, Li F, Fang X, Zhao C. Contralateral delayed hematoma secondary to anticoagulant treatment-related intracerebral hemorrhage. Neuro Endocrinol Lett. 2013 Jan; 34(5): 343-346